# Hyperglucagonaemia in Patients With Type 2 Diabetes - Role of Glucagon Clearance

> **NCT02475421** · NA · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 32 (actual)

## Conditions studied

- Diabetes

## Interventions

- **BIOLOGICAL:** Glucagon

## Key facts

- **NCT ID:** NCT02475421
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-12
- **Final completion:** 2017-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-10-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02475421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02475421, "Hyperglucagonaemia in Patients With Type 2 Diabetes - Role of Glucagon Clearance". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02475421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*